BRUP‐1, an intracellular bilirubin modulator, exerts neuroprotective activity in a cellular Parkinson’s disease model
- 3 March 2020
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 155 (1) , 81-97
Abstract
Bilirubin, the end product of heme redox metabolism, has cytoprotective properties and is an essential metabolite associated with cardiovascular disease, inflammatory bowel disease, type 2 diabetes, and neurodegenerative diseases including Parkinson's disease (PD). PD is characterized by progressive degeneration of nigral dopaminergic neurons and is associated with elevated oxidative stress due to mitochondrial dysfunction. In this study, using a ratiometric bilirubin probe, we revealed that the mitochondrial inhibitor, rotenone, which is widely used to create a PD model, significantly decreased intracellular bilirubin levels in HepG2 cells. Chemical screening showed that BRUP‐1 was a top hit that restored cellular bilirubin levels that were lowered by rotenone. We found that BRUP‐1 up‐regulated the expression level of heme oxygenase‐1 (HO‐1), one of the rate‐limiting enzyme of bilirubin production via nuclear factor erythroid 2‐related factor 2 (Nrf2) activation. In addition, we demonstrated that this Nrf2 activation was due to a direct inhibition of the interaction between Nrf2 and Kelch‐like ECH‐associated protein 1 (Keap1) by BRUP‐1. Both HO‐1 up‐regulation and bilirubin restoration by BRUP‐1 treatment were significantly abrogated by Nrf2 silencing. In neuronal PC12D cells, BRUP‐1 also activated the Nrf2‐HO‐1 axis and increased bilirubin production, resulted in the suppression of neurotoxin‐induced cell death, reactive oxygen species production, and protein aggregation, which are hallmarks of PD. Furthermore, BRUP‐1 showed neuroprotective activity against rotenone‐treated neurons derived from induced pluripotent stem cells. These findings provide a new member of Keap1‐Nrf2 direct inhibitors and suggest that chemical modulation of heme metabolism using BRUP‐1 may be beneficial for PD treatment. imageKeywords
Funding Information
- Japan Agency for Medical Research and Development (AMED‐CREST, JP17ek0109244, JP19am0101086)
- Japan Society for the Promotion of Science (18K15463, 19J12969)
- RIKEN
- Keio University
This publication has 76 references indexed in Scilit:
- Carbon Monoxide Modulates Apoptosis by Reinforcing Oxidative Metabolism in AstrocytesJournal of Biological Chemistry, 2012
- p62/SQSTM1 Is a Target Gene for Transcription Factor NRF2 and Creates a Positive Feedback Loop by Inducing Antioxidant Response Element-driven Gene TranscriptionJournal of Biological Chemistry, 2010
- Limited Role for the Bilirubin-Biliverdin Redox Amplification Cycle in the Cellular Antioxidant Protection by Biliverdin ReductaseJournal of Biological Chemistry, 2009
- The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative StressJournal of Biological Chemistry, 2009
- Bilirubin and glutathione have complementary antioxidant and cytoprotective rolesProceedings of the National Academy of Sciences, 2009
- Multiple Nuclear Localization Signals Function in the Nuclear Import of the Transcription Factor Nrf2Journal of Biological Chemistry, 2008
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairmentFree Radical Biology and Medicine, 2007
- Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signalingThe EMBO Journal, 2006
- Neurodegenerative diseases and oxidative stressNature Reviews Drug Discovery, 2004